Monday, September 14, 2026

ABL209: The Promising Dual Antibody ADC Revolutionizing Cancer Treatment in 2026

ABL Bio's ABL209 shows promising anti-cancer effects with broad safety in preclinical studies, advancing to Phase 1 trials in the U.S.

Krafton vs. ChatGPT: How AI Influenced a Major CEO Reinstatement in the Gaming Industry

A U.S. court ordered Krafton to reinstate CEO Ted Gill after the company relied on ChatGPT's advice during a management dispute.

How K-Bio is Set to Thrive Amid U.S. Regulation Changes for Biosimilars in 2027

Major countries are easing biosimilar regulations, boosting K-Bio opportunities and reducing development costs by up to 90%.

Tag: KOSDAQ listing

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.